Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

Germany flag Germany · Delayed Price · Currency is EUR
1.800
0.00 (0.00%)
Last updated: Apr 23, 2026, 9:49 PM CET
Market Cap4.39B -16.9%
Revenue (ttm)9.46B +3.6%
Net Income363.25M +5.2%
EPS0.22 +5.2%
Shares Outn/a
PE Ratio12.08
Forward PE12.43
Dividend0.10 (5.36%)
Ex-Dividend DateAug 29, 2025
Volume200
Average Volume10
Open1.800
Previous Close1.800
Day's Range1.800 - 1.800
52-Week Range1.790 - 2.300
Betan/a
RSI36.32
Earnings DateApr 27, 2026

About FRA:GU5

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1997
Employees 27,057
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GU5

Financial Performance

In 2025, FRA:GU5's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY Financial Statements